ConductScience.org, home

Paper36978342

Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.

Ruiz-Ramos J and 2 others. Antibiotics (Basel), 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria. Papers, record 36978342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2023-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ruiz-Ramos JJesushttps://orcid.org/0000-0002-0008-641X
2Gras-Martín LLaura
3Ramírez PPaulahttps://orcid.org/0000-0002-7598-3350

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135699444
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia.
Antimicrob Agents Chemother2022https://conductscience.org/library/papers/35699444PubMed
211181370Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11181370PubMed
328948652Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.J Clin Pharm Ther2017https://conductscience.org/library/papers/28948652PubMed
412972447Overstretching the mutant prevention concentration.J Antimicrob Chemother2003https://conductscience.org/library/papers/12972447PubMed
530478168Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30478168PubMed
634041714Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction.Clin Pharmacokinet2021https://conductscience.org/library/papers/34041714PubMed
736289971A Systematic Review of the Effect of Therapeutic Drug Monitoring on Patient Health Outcomes during Treatment with Carbapenems.Antibiotics (Basel)2022https://conductscience.org/library/papers/36289971PubMed
824768475Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.Lancet Infect Dis2014https://conductscience.org/library/papers/24768475PubMed
935722356Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.Ann Transl Med2022https://conductscience.org/library/papers/35722356PubMed
1033165876Pharmacokinetics of ciprofloxacin during continuous renal replacement therapy in intensive care patients - new assessment.Anaesthesiol Intensive Ther2020https://conductscience.org/library/papers/33165876PubMed
1123190792ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.BMC Anesthesiol2012https://conductscience.org/library/papers/23190792PubMed
1235023902Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.Drug Des Devel Ther2022https://conductscience.org/library/papers/35023902PubMed
1324046298Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.Clin Infect Dis2013https://conductscience.org/library/papers/24046298PubMed
1431325141What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review.Clin Pharmacokinet2019https://conductscience.org/library/papers/31325141PubMed
1518725438Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18725438PubMed
1622511133Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.Crit Care Med2012https://conductscience.org/library/papers/22511133PubMed
1729732181Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.J Thorac Dis2018https://conductscience.org/library/papers/29732181PubMed
1835631551Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study.Pharmaceutics2022https://conductscience.org/library/papers/35631551PubMed
1921059616Pharmacokinetic-pharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease.J Antimicrob Chemother2011https://conductscience.org/library/papers/21059616PubMed
2020862453Determinants of drug absorption in different ECMO circuits.Intensive Care Med2010https://conductscience.org/library/papers/20862453PubMed

See all 103 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42711757
Prediction of the clinical outcomes of imipenem and meropenem in patients with treatment-associated AKI and death via machine learning models combined with pharmacokinetic parameters: A retrospective cohort study.
Sci Prog2026https://conductscience.org/library/papers/42711757PubMed
42450304Cutaneous Staphylococcus aureus Infections in Renal Edema Across Kidney Disease and the Intensive Care Unit: Pathophysiological Mechanisms, Clinical Implications, and Therapeutic Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42450304PubMed
42266929Artificial intelligence in optimizing antimicrobial therapy for gastro-renal disorders.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42266929PubMed
41586496
Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study.
Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41586496PubMed
41510531Infection and antibiotic patterns in critically ill patients on extracorporeal membrane oxygenation.Turk Gogus Kalp Damar Cerrahisi Derg2025https://conductscience.org/library/papers/41510531PubMed
40162439Beta-hemolytic Streptococci in respiratory illness.Bioinformation2024https://conductscience.org/library/papers/40162439PubMed
39858350Evaluation of the Bacterial Infections and Antibiotic Prescribing Practices in the Intensive Care Unit of a Clinical Hospital in Romania.Antibiotics (Basel)2025https://conductscience.org/library/papers/39858350PubMed
39200006Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.Antibiotics (Basel)2024https://conductscience.org/library/papers/39200006PubMed
38252038Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence.Future Microbiol2024https://conductscience.org/library/papers/38252038PubMed
38247631Translational PK/PD for the Development of Novel Antibiotics-A Drug Developer's Perspective.Antibiotics (Basel)2024https://conductscience.org/library/papers/38247631PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CST31471PubTator's text mininghttps://conductscience.org/library/genes/1471NCBI Gene
HMGA28091PubTator's text mininghttps://conductscience.org/library/genes/8091NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36978342

GET https://conductscience.org/api/papers/v1/36978342/references?page=2